morningstar.com
FDA Approval of Eli Lilly's Omvoh for Crohn's Disease Adds a New Option, but Uptake May ...
Cure8 flagged this item because the article title and available source metadata connect it to Crohn's disease, Mirikizumab, IL-23 inhibitor, and Medications. We do not yet have enough reliable article text to summarize the details.
This may be most useful for Adult patients and Clinicians following Crohn's disease, Mirikizumab, IL-23 inhibitor, and Medications.
What To Know
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a fda approval related to Crohn's disease, Mirikizumab, IL-23 inhibitor, and Medications. Use the original source link for the full details.
Because the source may be tied to a company, announcement, or business update, it is worth reading the original article for context and limitations.
